BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kevin T. Conroy, Former Third Wave Technologies, Inc. (TWTI) CEO, Joins Prodesse, Inc. Board


5/13/2009 12:54:11 PM

MILWAUKEE, Wis., May 13, 2009 – Prodesse Inc. today announced that Kevin T. Conroy has been elected to the company's board of directors.

Mr. Conroy, 43, was appointed president and chief executive of the molecular diagnostics company Exact Sciences Corp. in April 2009. He served as president and chief executive of Third Wave Technologies Inc., also a molecular diagnostics company, from December 2005 until the company’s acquisition by Hologic Inc. in July 2008. Prior to joining Third Wave, Mr. Conroy served as intellectual property counsel at GE Healthcare. Mr. Conroy also served as chief operating officer of two early-stage, venture-backed technology companies in Northern California. Prior to those positions, he was an intellectual property litigator at two Chicago law firms, McDermott Will & Emery, and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. Mr. Conroy earned a bachelor’s of science degree in electrical engineering at Michigan State University and a law degree from the University of Michigan.

"Kevin has a terrific reputation in the diagnostics field as a proven leader and strategic thinker,” said Tom Shannon, president and chief executive of Prodesse. “We are thrilled to add Kevin to our team of experienced board members and look forward to his leadership as we work diligently to continue the substantial growth being driven by Prodesse’s unique products."

About Prodesse

Prodesse is a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious disease applications. The company’s products are designed based on a combination of Prodesse’s patented technologies and other licensed technologies. Prodesse sells FDA 510(k) cleared products worldwide, CE Marked in vitro diagnostic kits outside the US and research use only kits worldwide. The company’s products can be used on multiple nucleic acid extraction and real-time PCR platforms. Prodesse also operates a CLIA certified laboratory for testing services in the Midwest area. For more information about Prodesse and its products, call 888-589-6974 or go to www.prodesse.com.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES